HE

Haque Ehteshamul Ansari

Active Director Director DIN 10181654
DIN 10181654 First appointment May 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Haque Ehteshamul Ansari

Data last updated:

Haque Ehteshamul Ansari is a Director at Megagenome Patho Lab And Health Plus Research Centre Private Limited (since 2023).

DIN 10181654
Primary Designation Director
First Appointment 29 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 May 20232023Active

Board colleagues of Haque Ehteshamul Ansari

Directorship timeline

Open interactive timeline →
Megagenome Patho Lab And Health Plus Research Centre Private Limited
Premium access

Shareholding and investment profile for Haque Ehteshamul Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Haque Ehteshamul Ansari

Haque Ehteshamul Ansari currently holds 1 directorship: Megagenome Patho Lab And Health Plus Research Centre Private Limited (Director, since 29 May 2023).

Haque Ehteshamul Ansari was first appointed on 29 May 2023 as Director at Megagenome Patho Lab And Health Plus Research Centre Private Limited.

The current boards of Haque Ehteshamul Ansari's companies include Tohid Ahmed (Megagenome Patho Lab And Health Plus Research Centre Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available